Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery Disease

NCT01566201 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis
Coronary Artery Disease
Inflammation

Interventions

DRUG: anakinra
DRUG: placebo

Sponsor

University of Athens